Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Relative survival benefit and morbidity with fluids in severe sepsis - a network meta-analysis of alternative therapies.

Bansal M, Farrugia A, Balboni S, Martin G.

Curr Drug Saf. 2013 Sep;8(4):236-45. Review.

2.

Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature.

Serpa Neto A, Veelo DP, Peireira VG, de Assunção MS, Manetta JA, Espósito DC, Schultz MJ.

J Crit Care. 2014 Feb;29(1):185.e1-7. doi: 10.1016/j.jcrc.2013.09.031. Epub 2013 Oct 22. Review.

PMID:
24262273
3.

Fluid replacement with hydroxyethyl starch in critical care--a reassessment.

Hartog CS, Welte T, Schlattmann P, Reinhart K.

Dtsch Arztebl Int. 2013 Jun;110(26):443-50. doi: 10.3238/arztebl.2013.0443. Epub 2013 Jun 28. Review.

4.

Hydroxyethyl starch in sepsis.

Haase NR.

Dan Med J. 2014 Jan;61(1):B4764.

PMID:
24393593
5.

Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials.

He B, Xu B, Xu X, Li L, Ren R, Chen Z, Xiao J, Wang Y, Xu B.

Crit Care. 2015 Mar 19;19:92. doi: 10.1186/s13054-015-0833-9.

6.

Comparison of hydroxyethyl starch colloids with crystalloids for surgical patients: A systematic review and meta-analysis.

Raiman M, Mitchell CG, Biccard BM, Rodseth RN.

Eur J Anaesthesiol. 2016 Jan;33(1):42-8. doi: 10.1097/EJA.0000000000000328. Review.

PMID:
26351826
7.

Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis.

Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, Wetterslev J.

BMJ. 2013 Feb 15;346:f839. doi: 10.1136/bmj.f839. Review.

8.

Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality.

Patel A, Laffan MA, Waheed U, Brett SJ.

BMJ. 2014 Jul 22;349:g4561. doi: 10.1136/bmj.g4561. Review. Erratum in: BMJ. 2014;349:g4850.

9.

Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis.

Bayer O, Reinhart K, Kohl M, Kabisch B, Marshall J, Sakr Y, Bauer M, Hartog C, Schwarzkopf D, Riedemann N.

Crit Care Med. 2012 Sep;40(9):2543-51.

PMID:
22903091
10.

Fluid resuscitation in sepsis: a systematic review and network meta-analysis.

Rochwerg B, Alhazzani W, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, Mbuagbaw L, Szczeklik W, Alshamsi F, Altayyar S, Ip WC, Li G, Wang M, Wludarczyk A, Zhou Q, Guyatt GH, Cook DJ, Jaeschke R, Annane D; Fluids in Sepsis and Septic Shock Group..

Ann Intern Med. 2014 Sep 2;161(5):347-55. doi: 10.7326/M14-0178. Review.

PMID:
25047428
11.

Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis.

Rochwerg B, Alhazzani W, Gibson A, Ribic CM, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, Mbuagbaw L, Szczeklik W, Alshamsi F, Altayyar S, Ip W, Li G, Wang M, Włudarczyk A, Zhou Q, Annane D, Cook DJ, Jaeschke R, Guyatt GH; FISSH Group (Fluids in Sepsis and Septic Shock)..

Intensive Care Med. 2015 Sep;41(9):1561-71. doi: 10.1007/s00134-015-3794-1. Epub 2015 Apr 23. Review.

PMID:
25904181
12.

Choice of Fluids in Severe Septic Patients - A Cost-effectiveness Analysis Informed by Recent Clinical Trials.

Farrugia A, Bansal M, Balboni S, Kimber MC, Martin GS, Cassar J.

Rev Recent Clin Trials. 2014;9(1):21-30.

13.

Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis.

Müller RB, Haase N, Lange T, Wetterslev J, Perner A.

Acta Anaesthesiol Scand. 2015 Mar;59(3):329-36. doi: 10.1111/aas.12453. Epub 2014 Dec 18.

PMID:
25524831
14.

Colloids versus crystalloids for fluid resuscitation in critically ill patients.

Perel P, Roberts I, Ker K.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD000567. doi: 10.1002/14651858.CD000567.pub6. Review.

PMID:
23450531
15.

Intravenous fluids in sepsis: what to use and what to avoid.

Karakala N, Raghunathan K, Shaw AD.

Curr Opin Crit Care. 2013 Dec;19(6):537-43. doi: 10.1097/MCC.0000000000000028. Review.

PMID:
24240819
16.

New insights into fluid resuscitation.

Myburgh J, McIntyre L.

Intensive Care Med. 2013 Jun;39(6):998-1001. doi: 10.1007/s00134-013-2890-3. Epub 2013 Apr 5.

PMID:
23559078
17.

Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials.

Xu JY, Chen QH, Xie JF, Pan C, Liu SQ, Huang LW, Yang CS, Liu L, Huang YZ, Guo FM, Yang Y, Qiu HB.

Crit Care. 2014 Dec 15;18(6):702. doi: 10.1186/s13054-014-0702-y.

18.

Colloids versus crystalloids for fluid resuscitation in critically ill patients.

Perel P, Roberts I.

Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000567. doi: 10.1002/14651858.CD000567.pub5. Review. Update in: Cochrane Database Syst Rev. 2013;(2):CD000567.

PMID:
22696320
19.

Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.

Mutter TC, Ruth CA, Dart AB.

Cochrane Database Syst Rev. 2013 Jul 23;(7):CD007594. doi: 10.1002/14651858.CD007594.pub3. Review.

PMID:
23881659
20.

Individual patient data meta-analysis of hydroxyethyl starch 130/0.4-0.42 versus crystalloid for fluid resuscitation in patients with severe sepsis: a statistical analysis plan.

Hammond NE, Haase N, Billot L, Wetterslev J, Saxena MK, Finfer S, Perner A, Myburgh J.

Crit Care Resusc. 2014 Jun;16(2):96-103.

PMID:
24888279

Supplemental Content

Support Center